PrEP is a measure to prevent HIV transmission, particularly for men who have high risk condomless sex with multiple male partners. A hearing was held in the High Court on Wednesday 13 July 2016 to consider whether NHS England had the legal power to commission the PrEP service. At the hearing, NHS England contended that it did not have the power to commission the […]
This vacancy is no longer available. NHS England is committed to ensuring that public and patient voices are at the centre of shaping our healthcare services. Every level of our commissioning system needs to be informed by insightful methods of listening to those who use and care about our services to inform service development. There […]
NHS England has today (11 July) set out the results of its annual process for deciding which new treatments and services it will make available to patients. Around a hundred policies were considered over the course of the year. Many of these were considered as ‘In Year Service Developments’ – policies which are cost-saving or […]
The number of patients receiving an innovative treatment for brain tumours will more than double over the next three years as a concrete step towards the implementation of NHS England’s Cancer Strategy. NHS England has now announced the award of new contracts for stereotactic radiosurgery and radiotherapy (SRS/SRT) – specialist forms of radiotherapy that can […]
PrEP is a way of using anti-retroviral drugs – usually used for treating people with diagnosed HIV- to stop viral transmission. Evidence of effectiveness is strongest for men who do not use condoms in sex with multiple male partners. On 21 March 2016, a statement was placed on the NHS England website explaining that PrEP could […]
NHS England has today announced that a collaboration between Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University has been awarded a contract to oversee the treatment of patients with aHUS, a rare, progressive condition which can lead to renal failure. Atypical Haemolytic Uraemic Syndrome (aHUS) is an extremely rare chronic condition which causes […]
NHS England ran a 30 day consultation on ‘Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents’ and ‘Treatment of iron overload for transfused and non transfused patients with chronic inherited anaemias’ early this year. The following documents that were part of the original suite of documents posted online as part of the […]
NHS England has launched a 30 day public consultation on two proposed new clinical commissioning policies for specialised services – specifically Rituximab for the treatment of Primary Sjogren’s Syndrome (PSS) in adults, and Rituximab in Connective Tissue Disease associated Interstitial Lung Disease in adults. There has already been extensive engagement on these policies. They have […]
NHS England has today launched a 30-day consultation on a proposed method to support decision-making on relative prioritisation in specialised commissioning. Each year, a significant number of proposals are put to NHS England for investment in new drugs, medical devices or interventions for use by specialised services in England. NHS England has to make difficult […]
NHS England has today announced a new nationwide system for purchasing expensive medical devices and implants which will see savings of over £60 million ploughed back into specialist care in its first two years. Currently NHS England spends £500 million a year reimbursing specialist units for devices such as implantable cardioverter defibrillators (ICDs) for people […]